Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $158.13 million. The enterprise value is $219.15 million.
| Market Cap | 158.13M |
| Enterprise Value | 219.15M |
Important Dates
The next estimated earnings date is Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 73.89 million shares outstanding. The number of shares has increased by 13.13% in one year.
| Current Share Class | 73.89M |
| Shares Outstanding | 73.89M |
| Shares Change (YoY) | +13.13% |
| Shares Change (QoQ) | +2.25% |
| Owned by Insiders (%) | 5.36% |
| Owned by Institutions (%) | 72.92% |
| Float | 58.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 235.16 |
| PS Ratio | 0.52 |
| Forward PS | 0.62 |
| PB Ratio | 1.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.59 |
| P/OCF Ratio | 8.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 11.96 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 1.23.
| Current Ratio | 1.69 |
| Quick Ratio | 1.56 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.31 |
| Interest Coverage | -11.40 |
Financial Efficiency
Return on equity (ROE) is -103.02% and return on invested capital (ROIC) is -4.17%.
| Return on Equity (ROE) | -103.02% |
| Return on Assets (ROA) | -3.48% |
| Return on Invested Capital (ROIC) | -4.17% |
| Return on Capital Employed (ROCE) | -81.15% |
| Weighted Average Cost of Capital (WACC) | 11.40% |
| Revenue Per Employee | $252,066 |
| Profits Per Employee | -$221,048 |
| Employee Count | 1,200 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $915,000 in taxes.
| Income Tax | 915,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.97% in the last 52 weeks. The beta is 1.57, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -44.97% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 55.90 |
| Average Volume (20 Days) | 781,176 |
Short Selling Information
The latest short interest is 3.65 million, so 4.93% of the outstanding shares have been sold short.
| Short Interest | 3.65M |
| Short Previous Month | 4.60M |
| Short % of Shares Out | 4.93% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $302.48 million and -$265.26 million in losses. Loss per share was -$3.74.
| Revenue | 302.48M |
| Gross Profit | 152.58M |
| Operating Income | -36.33M |
| Pretax Income | -264.34M |
| Net Income | -265.26M |
| EBITDA | -196.87M |
| EBIT | -247.16M |
| Loss Per Share | -$3.74 |
Balance Sheet
The company has $108.82 million in cash and $170.58 million in debt, with a net cash position of -$61.76 million or -$0.84 per share.
| Cash & Cash Equivalents | 108.82M |
| Total Debt | 170.58M |
| Net Cash | -61.76M |
| Net Cash Per Share | -$0.84 |
| Equity (Book Value) | 138.15M |
| Book Value Per Share | 1.87 |
| Working Capital | 74.70M |
Cash Flow
In the last 12 months, operating cash flow was $18.96 million and capital expenditures -$636,000, giving a free cash flow of $18.33 million.
| Operating Cash Flow | 18.96M |
| Capital Expenditures | -636,000 |
| Depreciation & Amortization | 37.20M |
| Net Borrowing | -232.29M |
| Free Cash Flow | 18.33M |
| FCF Per Share | $0.25 |
Margins
Gross margin is 50.44%, with operating and profit margins of -12.01% and -87.69%.
| Gross Margin | 50.44% |
| Operating Margin | -12.01% |
| Pretax Margin | -87.39% |
| Profit Margin | -87.69% |
| EBITDA Margin | -65.08% |
| EBIT Margin | -81.71% |
| FCF Margin | 6.06% |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.13% |
| Shareholder Yield | -13.13% |
| Earnings Yield | -168.53% |
| FCF Yield | 11.64% |
Analyst Forecast
The average price target for Health Catalyst is $2.25, which is 5.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.25 |
| Price Target Difference | 5.14% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -7.40% |
| EPS Growth Forecast (3Y) | -47.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -3.89 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.89 |
| Piotroski F-Score | 5 |